Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. William V. Williams M.D. | CEO, President & Director | 987.72k | -- | 1955 |
| Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. | CFO & Corporate Secretary | 595.79k | -- | 1973 |
| Dr. Miguel A. Lopez-Lago Ph.D. | Chief Scientific Officer | 481.13k | -- | 1969 |
| Dr. Giuseppe Del Priore M.D., M.P.H., MPH | Chief Medical Officer | 726.69k | -- | 1962 |
| Dr. Charles Louis Wiseman FACP, M.D. | Founder, Principal Research Advisor & Member of Scientific Advisory Board | 324.31k | -- | 1946 |
BriaCell Therapeutics Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Corporate Governance
Upcoming Events
March 17, 2025 at 8:00 PM UTC - March 21, 2025 at 8:00 PM UTC
BriaCell Therapeutics Corp. Earnings Date
Recent Events
January 2, 2020 at 12:00 AM UTC
Dividend Date